{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:36:48Z","timestamp":1740173808411,"version":"3.37.3"},"reference-count":15,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"vor","delay-in-days":271,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.medici.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:37:07Z","timestamp":1412037427000},"page":"245-248","source":"Crossref","is-referenced-by-count":3,"title":["Early prediction of response to cetuximab and radiotherapy by FDG-PET\/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx"],"prefix":"10.3390","volume":"50","author":[{"given":"Mindaugas","family":"Grybauskas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Daisne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardas","family":"Aleknavi\u010dius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvydas","family":"Burneckis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","reference":[{"year":"2010","series-title":"The Globocan Project [website on the Internet]","key":"10.1016\/j.medici.2014.09.003_bib0005"},{"key":"10.1016\/j.medici.2014.09.003_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.medici.2014.09.003_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medici.2014.09.003_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09674845.2011.11730344","article-title":"Predicting tumour response to anti-HER1 therapy using medical imaging: a literature review and in vitro study of [18F]-FDG incorporation by breast cancer cells responding to cetuximab","volume":"68","author":"Smith","year":"2011","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.medici.2014.09.003_bib0025","first-page":"309","article-title":"\u00dcber den stoffwechsel der carcinomzelle","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem Z"},{"key":"10.1016\/j.medici.2014.09.003_bib0030","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.medici.2014.09.003_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0969-8051(97)00226-6","article-title":"FDG accumulation and tumor biology","volume":"25","author":"Pauwels","year":"1998","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.medici.2014.09.003_bib0040","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.medici.2014.09.003_bib0045","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","article-title":"Assessing tumor hypoxia in cervical cancer by positron emission tomography with (60)Cu-ATSM: relationship to therapeutic response \u2013 a preliminary report","volume":"55","author":"Dehdashti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.medici.2014.09.003_bib0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2013.02.001","article-title":"Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models","volume":"106","author":"Stegeman","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.medici.2014.09.003_bib0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia \u2013 a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.medici.2014.09.003_bib0060","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/1535-7163.MCT-07-2187","article-title":"Requirement of hypoxia-inducible factor-1A downregulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab","volume":"7","author":"Li","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.medici.2014.09.003_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1476-4598-6-63","article-title":"Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1\u03b1","volume":"6","author":"Lu","year":"2007","journal-title":"Mol Cancer"},{"issue":"7","key":"10.1016\/j.medici.2014.09.003_bib0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"Hentschel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.medici.2014.09.003_bib0075","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-12-0011","article-title":"Early FDG\/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer","volume":"11","author":"Krystal","year":"2012","journal-title":"Mol Cancer Ther"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X14000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X14000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T16:06:25Z","timestamp":1525709185000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010660X14000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"alternative-id":["S1010660X14000688"],"URL":"https:\/\/doi.org\/10.1016\/j.medici.2014.09.003","relation":{},"ISSN":["1010-660X"],"issn-type":[{"type":"print","value":"1010-660X"}],"subject":[],"published":{"date-parts":[[2014]]}}}